Cited by 620Systemic Lupus Erythematosus ResearchReproductive System and PregnancyBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

Meroni, Pier Luigi, Borghi, M. Orietta, Raschi, Elena, Tedesco, Francesco·2011·Nature Reviews Rheumatology

DOI 10.1038/nrrheum.2011.52

Open this paper in CoChat — free account

Abstract

Antiphospholipid antibodies (aPL) are both diagnostic markers for, and pathogenic drivers of, antiphospholipid syndrome (APS). Although the presence of aPL is a necessary pre-condition, APS-associated clotting is seemingly triggered by an additional 'second hit', frequently related to innate inflammatory immune responses. β(2) glycoprotein I (β(2)GPI)-dependent aPL, the most important subset of these antibodies, mediate several--not necessarily alternative--thrombogenic mechanisms, mainly on the basis of their reactivity with β(2)GPI expressed on the membrane of cells that participate in the coagulation cascade. Recurrent pregnancy complications associated with aPL cannot be explained solely by thrombosis, and alternative pathogenic mechanisms have been reported. Although one in vivo model of fetal loss suggests a mechanism of aPL-mediated acute placental inflammation, other models and the histopathological examination of APS placentae do not support a widespread inflammatory signature. β(2)GPI-dependent aPL are thought to recognize their antigen on placental tissues, inhibit the growth and differentiation of trophoblasts, and eventually cause defective placentation. Why antibodies with similar antigen specificity produce different clinical manifestations is not clear. Characterization of the molecular basis of the pathogenic mechanisms involved, including the putative second hits and the role of complement activation, might offer an answer to this question.

Integrity signals

Registry

Crossref · 10.1038/nrrheum.2011.52

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Self-citation
Antiphospholipid syndrome
Ruiz‐Irastorza, G., Crowther, M. A., Branch, W. D., & Khamashta, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60709-x · Cited by 875
Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits
Tang, S.-C., Arumugam, T. V., Xu, X., Cheng, A., Mughal, M. R., Jo, D. G., Lathia, J. D., Siler, D. A., Chigurupati, S., Ouyang, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702553104 · Cited by 779
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P. B., Spruce, L. A., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18817 · Cited by 691
Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation
Girardi, G., Redecha, P. B., & Salmon, J. E. (2004) · Nature Medicine · doi:10.1038/nm1121 · Cited by 680
Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
Holers, V. M., Girardi, G., Mo, L., Guthridge, J. M., Molina, H. D., Pierangeli, S. S., Espinola, R. G., Xiaowei, L. E., Mao, D., Vialpando, C. G., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.200116116 · Cited by 625
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P. B., Spruce, L. A., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318817 · Cited by 593
Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment
Cowchock, F. S., Reece, E. A., Balaban, D. J., Branch, D. W., & Plouffe, L. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91596-3 · Cited by 585
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction
Girardi, G., Yarilin, D. A., Thurman, J. M., Holers, V. M., & Salmon, J. E. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061022 · Cited by 509
Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome
Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-11-3334 · Cited by 413
Requirement of activation of complement C3 and C5 for antiphospholipid antibody–mediated thrombophilia
Pierangeli, S. S., Girardi, G., Vega-Ostertag, M. E., Liu, X., Espinola, R. G., & Salmon, J. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21157 · Cited by 362
Evidence of Toll‐like receptor molecules on human platelets
Cognasse, F., Hamzeh, H., Chavarin, P., Acquart, S., Genin, C., & Garraud, O. (2005) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2005.01314.x · Cited by 361
Thrombus formation induced by antibodies to β2-glycoprotein I is complement dependent and requires a priming factor
Fabio Fischetti, I., Durigutto, P., Pellis, V., Debeus, A., Macor, P., Bulla, R., Bossi, F., Ziller, F., Sblattero, D., Meroni, P. L., et al. (2005) · Blood · doi:10.1182/blood-2005-03-1319 · Cited by 352
Self-citation
The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity
Tedesco, F., Pausa, M., Nardon, E., Introna, M., Mantovani, A., & Dobrina, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1619 · Cited by 316
Self-citation
Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies
Raschi, E., Testoni, C., Bosisio, D., Borghi, M. O., Koike, T., Mantovani, A., & Meroni, P. L. (2003) · Blood · doi:10.1182/blood-2002-08-2349 · Cited by 304
Self-citation
Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody–induced fetal injury
Redecha, P. B., Tilley, R. E., Tencati, M., Salmon, J. E., Kirchhofer, D., Mackman, N., & Girardi, G. (2007) · Blood · doi:10.1182/blood-2007-01-070631 · Cited by 293
The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study
DE LAAT, B., PENGO, V., PABINGER, I., MUSIAL, J., VOSKUYL, A. E., BULTINK, I. E. M., RUFFATTI, A., ROZMAN, B., KVEDER, T., DE MOERLOOSE, P., et al. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03588.x · Cited by 291
REVIEW ARTICLE: Toll‐Like Receptors at the Maternal–Fetal Interface in Normal Pregnancy and Pregnancy Disorders
Koga, K., & Mor, G. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00848.x · Cited by 288
β2-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome
Ağar, Ç., OS, G. M. A. V., Mörgelin, M., Sprenger, R. R., Marquart, J. A., Urbanus, R. T., Derksen, R. H. W. M., Meijers, J. C. M., & de Groot, P. G. (2010) · Blood · doi:10.1182/blood-2009-12-260976 · Cited by 262
TNF-α Is a Critical Effector and a Target for Therapy in Antiphospholipid Antibody-Induced Pregnancy Loss
Berman, J., Girardi, G., & Salmon, J. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.485 · Cited by 242
The Th1/Th2 paradigm: still important in pregnancy?
Chaouat, G. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0069-0 · Cited by 231
Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphos pholipid antibodies and recurrent spontaneous abortion
Rand, J. H., Wu, X.-X., Guller, S. M., Gil, J., Guha, A., Scher, J., & Lockwood, C. J. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(94)90403-0 · Cited by 229
Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies
Pierangeli, S. S., Vega-Ostertag, M. E., Raschi, E., Liu, X., Romay‐Penabad, Z., Micheli, V. D., Galli, M., Moia, M., Tincani, A., Borghi, M. O., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.065037 · Cited by 224
Self-citation
Complement activation in patients with primary antiphospholipid syndrome
Oku, K., Atsumi, T., Bohgaki, M., Amengual, O., Kataoka, H., Horita, T., Yasuda, S., & Koike, T. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.090670 · Cited by 219
Antiphospholipid Antibodies and the Antiphospholipid Syndrome: Pathogenic Mechanisms
Pierangeli, S. S., Chen, P. P., Raschi, E., Scurati, S., Grossi, C., Borghi, M. O., Palomo, I. F., Harris, E. N., & Meroni, P. L. (2008) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0028-1082267 · Cited by 218
Self-citation
Current concepts on the pathogenesis of the antiphospholipid syndrome
Giannakopoulos, B., Passam, F. H., Rahgozar, S., & Krilis, S. A. (2006) · Blood · doi:10.1182/blood-2006-04-001206 · Cited by 217
Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies
Zhang, J., & McCrae, K. R. (2004) · Blood · doi:10.1182/blood-2004-05-1708 · Cited by 212
ORIGINAL ARTICLE: Antiphospholipid Antibodies Induce a Pro‐Inflammatory Response in First Trimester Trophoblast Via the TLR4/MyD88 Pathway
Mulla, M. J., Brosens, J. J., Chamley, L., Giles, I., Pericleous, C., Rahman, A., Joyce, S. K., Panda, B., Paidas, M. J., & Abrahams, V. M. (2009) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2009.00717.x · Cited by 207
Infectious origin of the antiphospholipid syndrome
Shoenfeld, Y., Blank, M., Cervera, R., Font, J., Raschi, E., & Meroni, P. L. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.045443 · Cited by 206
Self-citation
Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies
Shamonki, J. M., Salmon, J. E., Hyjek, E. M., & Baergen, R. N. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.10.879 · Cited by 203
Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome
Redecha, P. B., Franzke, C.-W., Ruf, W., Mackman, N., & Girardi, G. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36089 · Cited by 201
Antiphospholipid antibodies promote leukocyte–endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2
Ramesh, S., Morrell, C. N., Tarango, C., Thomas, G. D., Yuhanna, I. S., Girardi, G., Herz, J., Urbanus, R. T., de Groot, P. G., Thorpe, P. E., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39828 · Cited by 195
Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6
Martinez de la Torre, Y., Buracchi, C., Borroni, E. M., Dupor, J., Bonecchi, R., Nebuloni, M., Pasqualini, F., Doni, A., Lauri, E., Agostinis, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607514104 · Cited by 178
Self-citation
Thrombogenicity of β2-glycoprotein I–dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster
Jankowski, M., Vreys, I., Wittevrongel, C., Boon, D., Vermylen, J., Hoylaerts, M., & Arnout, J. (2002) · Blood · doi:10.1182/blood-2002-05-1310 · Cited by 175
Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study
Galli, M., Borrelli, G., Jacobsen, E. M., Marfisi, R. M., Finazzi, G., Marchioli, R., Wisloff, F., Marziali, S., Morboeuf, O., & Barbui, T. (2007) · Blood · doi:10.1182/blood-2007-01-066043 · Cited by 170
A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice
Thurman, J. M., Kraus, D., Girardi, G., Hourcade, D. E., Kang, H. J., Royer, P. A., Mitchell, L. M., Giclas, P. C., Salmon, J. E., Gilkeson, G. S., et al. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.043 · Cited by 162
The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis
Rand, J., Xx, W., Quinn, A., & Taatjes, D. J. (2010) · Lupus · doi:10.1177/0961203310361485 · Cited by 143
The anti-beta2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native β2-glycoprotein I and preserved during species' evolution
Tincani, A., Spatola, L., Prati, E., Allegri, F., Ferremi, P., Cattaneo, R., Meroni, P. L., & Balestrieri, G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5732 · Cited by 133
Self-citation
Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo
Romay‐Penabad, Z., Montiel-Manzano, M. G., Shilagard, T., Papalardo, E., Vargas, G., Deora, A. B., Wang, M., Jacovina, A. T., Garcı́a-Latorre, E., Reyes‐Maldonado, E., et al. (2009) · Blood · doi:10.1182/blood-2008-11-188698 · Cited by 132
In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of β2-glycoprotein I: proof of concept
Ioannou, Y., Penabad, Z. R., Pericleous, C., Giles, I., Papalardo, E., Vargas, G., Shilagard, T., Latchman, D. S., Isenberg, D. A., Rahman, A., et al. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03316.x · Cited by 130
Platelet activation by dimeric β2‐glycoprotein I requires signaling via both glycoprotein Ibα and apolipoprotein E receptor 2′
Urbanus, R. T., Pennings, M. T. T., Derksen, R. H. W. M., & de Groot, P. G. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03021.x · Cited by 129
Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome
Romay‐Penabad, Z., Aguilar‐Valenzuela, R., Urbanus, R. T., Derksen, R. H. W. M., Pennings, M. T. T., Papalardo, E., Shilagard, T., Vargas, G., Hwang, Y. G., de Groot, P. G., et al. (2010) · Blood · doi:10.1182/blood-2010-07-299099 · Cited by 126
Pathogenic role of anti-β2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of β2-glycoprotein I binding to trophoblast cells and functional effects of anti-β2-glycoprotein I antibodies in vitro
Simone, N. D., Raschi, E., Testoni, C., Castellani, R., D'Asta, M., Shi, T., Krilis, S. A., Caruso, A., & Meroni, P. L. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.021444 · Cited by 124
Self-citation
Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome.
Rosa, L. L., Meroni, P. L., Tincani, A., Balestrieri, G., Faden, D. F., Lojacono, A., Morassi, L., Brocchi, E., Papa, N. D., & Gharavi, A. E. (1994) · PubMed · Cited by 123
Self-citation
Thrombogenic Properties of Murine Anti-Cardiolipin Antibodies Induced by β 2 Glycoprotein 1 and Human Immunoglobulin G Antiphospholipid Antibodies
Pierangeli, S. S., Liu, X. W., Anderson, G., Barker, J. H., & Harris, E. N. (1996) · Circulation · doi:10.1161/01.cir.94.7.1746 · Cited by 118
Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells
Yang, X. V., Banerjee, Y., Fernández, J. A., Deguchi, H., Xu, X., Mosnier, L. O., Urbanus, R. T., de Groot, P. G., White-Adams, T. C., McCarty, O. J. T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807594106 · Cited by 116
Functional Proteomics: Examining the Effects of Hypoxia on the Cytotrophoblast Protein Repertoire
Hoang, V. M., Foulk, R. A., Clauser, K. R., Burlingame, A. L., Gibson, B. W., & Fisher, S. J. (2001) · Biochemistry · doi:10.1021/bi0023910 · Cited by 115
Antiprothrombin antibodies detected in two different assay systems
Atsumi, T., Koike, T., Hughes, G. R. V., Khamashta, M. A., & Bertolaccini, M. L. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-06-0382 · Cited by 113
Heparan Sulfate Proteoglycans Function as Receptors for Fibroblast Growth Factor-2 Activation of Extracellular Signal–Regulated Kinases 1 and 2
Chua, C. C., Rahimi, N., Forsten‐Williams, K., & Nugent, M. A. (2003) · Circulation Research · doi:10.1161/01.res.0000112965.70691.ac · Cited by 103
Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome: A case report and review of the literature
Nayar, R., & Lage, J. M. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90377-9 · Cited by 95
Impaired Fibrinolysis in the Antiphospholipid Syndrome
Krone, K. A., Allen, K. L., & McCrae, K. R. (2010) · Current Rheumatology Reports · doi:10.1007/s11926-009-0075-4 · Cited by 91
E-Selectin mediates pathogenic effects of antiphospholipid antibodies
Espinola, R. G., Liu, X., Colden‐Stanfield, M., Hall, J., Harris, E. N., & Pierangeli, S. S. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00119.x · Cited by 91
Mechanisms of Disease: antiphospholipid antibodies—from clinical association to pathologic mechanism
de Laat, B., Mertens, K., & de Groot, P. G. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0740 · Cited by 90
The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies
Satta, N., Dunoyer-Geindre, S., Reber, G., Fish, R. J., Boehlen, F., Kruithof, E. K. O., & de Moerloose, P. (2006) · Blood · doi:10.1182/blood-2005-03-024463 · Cited by 88
Impaired expression of endometrial differentiation markers and complement regulatory proteins in patients with recurrent pregnancy loss associated with antiphospholipid syndrome
Francis, J. (2006) · Molecular Human Reproduction · doi:10.1093/molehr/gal048 · Cited by 84
Antiendothelial cell antibodies in systemic lupus erythematosus
Renaudineau, Y., Dugué, C., Dueymes, M., & Youinou, P. (2002) · Autoimmunity Reviews · doi:10.1016/s1568-9972(02)00063-0 · Cited by 83
TLR2 Is One of the Endothelial Receptors for β2-Glycoprotein I
Alard, J.-É., Gaillard, F., Daridon, C., Shoenfeld, Y., Jamin, C., & Youinou, P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000526 · Cited by 80
Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies
Seshan, S. V., Franzke, C.-W., Redecha, P. B., Monestier, M., Mackman, N., & Girardi, G. (2009) · Blood · doi:10.1182/blood-2009-01-199117 · Cited by 80
Role of p38 mitogen‐activated protein kinase in antiphospholipid antibody‐mediated thrombosis and endothelial cell activation
Vega-Ostertag, M. E., Ferrara, D. E., Romay‐Penabad, Z., Xiang‐dong, L. I. U., Taylor, W. R., Colden‐Stanfield, M., & Pierangeli, S. S. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02680.x · Cited by 79
Effects of Polyclonal IgG Derived from Patients with Different Clinical Types of the Antiphospholipid Syndrome on Monocyte Signaling Pathways
Lambrianides, A., Carroll, C. J., Pierangeli, S. S., Pericleous, C., Branch, W. D., Rice, J., Latchman, D. S., Townsend, P. A., Isenberg, D. A., Rahman, A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902765 · Cited by 78
Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunity
Meroni, P. L. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.11.014 · Cited by 76
Self-citation
Complement activation in anti-phospholipid syndrome: A clue for an inflammatory process?
Cavazzana, I., Nebuloni, M., Cetin, I., Acaia, B., Sara, S., Borghi, M. O., Tincani, A., Tedesco, F., & Meroni, P. L. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.02.013 · Cited by 73
Self-citation
A peptide that mimics the Vth region of β2glycoprotein I reverses antiphospholipid-mediated thrombosis in mice
Vega-Ostertag, M. E., Liu, X., Henderson, V. J., & Pierangeli, S. S. (2006) · Lupus · doi:10.1191/0961203306lu2315oa · Cited by 72
Cell surface proteoglycan expression during maturation of human monocytes-derived dendritic cells and macrophages
Wegrowski, Y., Milard, A.-L., Kotlarz, G., Toulmonde, E., Maquart, F.-X., & Bernard, J. (2006) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2006.03059.x · Cited by 70
Beta 2 glycoprotein I is a substrate of thiol oxidoreductases
Passam, F. H., Rahgozar, S., Qi, M., Raftery, M. J., Wong, J. W. H., Tanaka, K., Ioannou, Y., Zhang, J. Y., Gemmell, R., Qi, J. C., et al. (2010) · Blood · doi:10.1182/blood-2010-02-271494 · Cited by 70
Prevalence and Clinical Correlations of Antibodies Against Six β2-Glycoprotein-I-Related Peptides in the Antiphospholipid Syndrome
Shoenfeld, Y., Krause, I., Kvapil, F., Sulkes, J., Lev, S., von Landenberg, P., Font, J., Zaech, J., Cervera, R., Pietté, J. C., et al. (2003) · Journal of Clinical Immunology · doi:10.1023/a:1025321617304 · Cited by 68
Self-citation
Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?
Shoenfeld, Y., Meroni, P. L., & Toubi, E. (2009) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32832effdd · Cited by 66
Self-citation
Phospholipid Binding Plasma Proteins Required for Antiphospholipid Antibody Detection—An Overview
McIntyre, J. A., Wagenknecht, D. R., & Sugi, T. (1997) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1997.tb00198.x · Cited by 63
A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E‐selectin on endothelial cells
Vega-Ostertag, M. E., Liu, X., Kwan‐Ki, H., Chen, P. P., & Pierangeli, S. S. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06283.x · Cited by 62
Natural Catalytic Antibodies in Norm, Autoimmune, Viral, and Bacterial Diseases
Nevinsky, G. A., & Buneva, V. N. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.98 · Cited by 58
The Pathogenesis of Neural Injury in Animal Models of the Antiphospholipid Syndrome
Katzav, A., Shoenfeld, Y., & Chapman, J. (2009) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-009-8154-x · Cited by 57
The effect of immunoglobulin G fractions from patients with lupus anticoagulant on placental prostacyclin and thromboxane production
Peaceman, A. M., & Rehnberg, K. A. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90408-b · Cited by 55
Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view
Meroni, P. L., Tedesco, F., Locati, M., Vecchi, A., Simone, N. D., Acaia, B., Pierangeli, S., & Borghi, M. O. (2010) · Lupus · doi:10.1177/0961203309361351 · Cited by 55
Self-citation
Annexin A2: biology and relevance to the antiphospholipid syndrome
Cockrell, E., Espinola, R., & McCrae, K. (2008) · Lupus · doi:10.1177/0961203308095329 · Cited by 50
An international multicentre‐laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti‐beta2‐glycoprotein autoantibodies
de Laat, B., Derksen, R. H. W. M., Reber, G., Musiał, J., Swadźba, J., Božič, B., Čučnik, S., Regnault, V., Forastiero, R. R., Woodhams, B. J., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04068.x · Cited by 49
Neonatal effects of maternal antiphospholipid syndrome
Tincani, A., Rebaioli, C. B., Andréoli, L., Lojacono, A., & Motta, M. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0010-8 · Cited by 40
Detection of Complement-fixing Antiphospholipid Antibodies in Association with Thrombosis
Saitô, T., Matsuda, K., Seino, J., Shibata, S., Sasaki, T., & Munakata, Y. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613900 · Cited by 37
Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity
Yang, Y., Chang, C., Chuang, Y., Hsu, H.-Y., Chen, P. P., & Chiang, B. (2009) · Rheumatology · doi:10.1093/rheumatology/kep328 · Cited by 35
Domain I of β2-glycoprotein I: its role as an epitope and the potential to be developed as a specific target for the treatment of the antiphospholipid syndrome
Ioannou, Y., & Rahman, A. (2010) · Lupus · doi:10.1177/0961203309360544 · Cited by 33
Antibodies to Serine Proteases in the Antiphospholipid Syndrome
Chen, P. P., & Giles, I. (2010) · Current Rheumatology Reports · doi:10.1007/s11926-009-0072-7 · Cited by 33
Role of Tissue Factor in the Maternal Immunological Attack of the Embryo in the Antiphospholipid Syndrome
Girardi, G. (2009) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-009-8187-1 · Cited by 32
Heparan Sulfate Proteoglycans in the Basement Membranes of the Human Placenta and Decidua
Chen, C.-P., Liu, S.-H., Lee, M.-Y., & Chen, Y.-Y. (2008) · Placenta · doi:10.1016/j.placenta.2008.01.002 · Cited by 29
Expression and function of syndecan-4 in human platelets
Kaneider, N. C., Feistritzer, C., Gritti, D., Mosheimer, B. A., Ricevuti, G., Patsch, J. R., & Wiedermann, C. J. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-11-0763 · Cited by 25
Glypican-1, Phosphacan/Receptor Protein-Tyrosine Phosphatase-ζ/β and its Ligand, Tenascin-C, are Expressed by Neural Stem Cells and Neural Cells Derived from Embryonic Stem Cells
Abaskharoun, M., Bellemare, M., Lau, E., & Margolis, R. U. (2010) · ASN NEURO · doi:10.1042/an20100001 · Cited by 23
Annexin A2 mediates anti-β2GPI/β2GPI-induced tissue factor expression on monocytes
Zhou (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000265 · Cited by 22
Placental Pathology in Antiphospholipid Syndrome
Parke, A. L. (2006) · Springer eBooks · doi:10.1007/1-84628-009-5_29 · Cited by 21
Reelin and apolipoprotein E receptor 2 in the embryonic and mature brain: effects of an evolutionary change in the apoER2 gene
Myant, N. B. (2009) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2009.1412 · Cited by 19
Reply
Martínez‐Lavín, M. (2008) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2007.09.006 · Cited by 3
Untitled work
Atsumi (2000) · doi:10.1002/1529-0131(200009)43:9

Research works printed but not linked: 5

Gerosa, M. et al. Complement involvement in antiphospholipid-mediated placental damage: prospective study in APS pregnant women [abstract THU0120] Ann. Rheum. Dis. 68 (Suppl. 3), 210 (2009).
Borghi, M. O. et al. Antiphospholipid antibodies reactivity with human decidual cells: an additional mechanism of pregnancy complications in APS and a potential target for innovative therapeutic intervention [abstract OP-0119]. Ann. Rheum. Dis. 68 (Suppl. 3), 109 (2009).
Raschi, E., Broggini, V., Borghi, M. O., Grossi, C. & Meroni, P. L. TLR-4 and Annexin A2 involvement in endothelial cell activation by anti-phospholipid antibodies: specific silencing by small interfering RNAs [abstract 1356]. Arthritis Rheum. 62 (Suppl.), S563 (2010).
Tedesco, F. Biodistribution of β2GPI in naive and immunized mice and in vivo pro-thrombotic effect of an anti-β2GPI minibody isolated from human phage display library [abstract A006]. Lupus 19, 497–498 (2010).
Ziglioli, T. et al. Low complement levels during pregnancy are associated with obstetric complications in patients with primary antiphospholipid syndrome [abstract THU0129]. Ann. Rheum. Dis. 68 (Suppl. 3), 213–214 (2009).

Sorted by citations

The Pathogenesis of the Antiphospholipid Syndrome
Giannakopoulos, B., & Krilis, S. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1112830 · Cited by 687
Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review
Lee, K. H., Kronbichler, A., Park, D. D.-Y., Park, Y. M., Moon, H., Kim, H., Choi, J. H., Choi, Y., Shim, S., Lyu, I. S., et al. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.09.012 · Cited by 643
Recurrent pregnancy loss: current perspectives
Hachem, H. E., Crepaux, V., May‐Panloup, P., Descamps, P., Legendre, G., & Bouet, P. (2017) · International Journal of Women s Health · doi:10.2147/ijwh.s100817 · Cited by 465
Estimated Frequency of Antiphospholipid Antibodies in Patients With Pregnancy Morbidity, Stroke, Myocardial Infarction, and Deep Vein Thrombosis: A Critical Review of the Literature
Andréoli, L., Chighizola, C. B., Banzato, A., Pons‐Estel, G., de Jesús, G. R., Erkan, D., & ACTION, O. B. O. A. (2013) · Arthritis Care & Research · doi:10.1002/acr.22066 · Cited by 363
Cardiovascular disease in autoimmune rheumatic diseases
Hollan, I., Meroni, P. L., Ahearn, J. M., Tervaert, J. W. C., Curran, S., Goodyear, C. S., Hestad, K. A., Kahaleh, B., Riggio, M. P., Shields, K. J., et al. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.03.013 · Cited by 278
Self-citation

See all 620

Authors: Meroni, P. L., Borghi, M. O., Raschi, E., & Tedesco, F.
Affiliations: University of Milan (IT)
IRCCS Istituto Auxologico Italiano (IT)
University of Trieste (IT)
Corresponding author: Meroni, Pier Luigi
ORCID: Meroni, Pier Luigi
Borghi, M. Orietta
Raschi, Elena
Tedesco, Francesco
Venue: Nature Reviews Rheumatology
Publisher: Springer Science and Business Media LLC
Published: 2011-05-10
Volume: 7
Issue: 6
Pages: 330-339
ISSN: 1759-4790 (ISSN-L)
1759-4804
DOI: 10.1038/nrrheum.2011.52
OpenAlex: W1999555834
Cited by: 620
References: 89
Citations by year: 2026: 38 · 2025: 34 · 2024: 35 · 2023: 34 · 2022: 39 · 2021: 47 · 2020: 34 · 2019: 41 · 2018: 43 · 2017: 43 · 2016: 54 · 2015: 33 · 2014: 63 · 2013: 37 · 2012: 36
FWCI: 6.72
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Reviews Rheumatology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords: antiphospholipid syndrome, antiphospholipid antibodies, beta2-glycoprotein I, thrombosis, recurrent pregnancy loss, placental inflammation, trophoblast differentiation, complement activation, innate immune response, autoantibody pathogenesis
MeSH terms: Female, Humans, Pregnancy, Pregnancy Complications, Antiphospholipid Syndrome, Antibodies, Antiphospholipid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks